Endothelial senescence in vascular diseases: current understanding and future opportunities in senotherapeutics – Experimental & Molecular Medicine
Aging arteries!
Related Articles
Opinion | Say Hello to Your Addiction Risk Score — Courtesy of the Tech Industry
A number of new tech companies want to solve the opioid crisis with algorithms. It’s a flawed and potentially harmful proposition.
Opinion | To Be (Visibly) Jewish in the Ivy League
Behavior that would be scandalous if aimed at other minorities are treated as understandable or even commendable when directed at Jews.
What’s at stake as the Supreme Court hears Idaho case about abortion in emergencies
The Supreme Court will consider the question: Should doctors treating pregnancy complications follow state or federal law if the laws conflict? Here’s how the case…
Bird flu virus found in grocery milk as officials say supply still safe
The finding does not suggest a threat to human health but indicates the avian flu virus is more widespread among dairy herds than previously thought.
Inflammatory Diseases Kindled When HDAC Proteins Act on Th17 Cells
Research shows two class II HDACs regulate cells that produce an important inflammatory cytokine associated with IBD and other disorders.
Joint Commission launches telehealth accreditation program
Hospitals, ambulatory care centers and behavioral health organizations that provide telehealth services will be eligible for the program effective July 1.
Call for Applications: AJKD Editorial Internship Program 2024-25
AJKD invites applications for its Editorial Internship Program, which will provide editorial experience to early career researchers interested in education, teaching, or medical editing/writing. AJ…
Musculoskeletal Manifestations of Sarcoidosis – Georges El Hasbani, Imad Uthman, Ali SM Jawad, 2022
Since its initial description in the late 19th century, sarcoidosis has been extensively studied. Although the general mechanism of immune activation is known, …
CheckMate-214 at 8 Years: Nivolumab + Ipilimumab Shows Durable Survival Benefit in Advanced RCC – Nizar Tannir
Pedro Barata and Nizar Tannir delve into the eight-year results of the CheckMate-214 trial, showcasing the sustained efficacy of ipilimumab and nivolumab (ipi/nivo) in advanced…
